Regarding "Clinical performance of drug-eluting stents with biodegradable polymeric coating: A meta-analysis and systematic review"

EuroIntervention

Volumn 8, Issue 5, 2012, Pages 642-643

  Rognoni, Andrea ^a   Santagostino, Matteo ^a   Sansa, Mara ^a   Bongo, Angelo Sante ^a   Lupi, Alessandro ^a  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOY; CHROMIUM; COBALT; POLYMER;

BIODEGRADATION; DRUG ELUTING STENT; HUMAN; LETTER; MATERIAL COATING; META ANALYSIS (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; REVASCULARIZATION; STENT; STENT THROMBOSIS; SYSTEMATIC REVIEW;

ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; COATED MATERIALS, BIOCOMPATIBLE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; POLYMERS;

EID: 84871677293     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV8I5A99     Document Type: Letter

References (7)

1. Ahmed TA, Bergheanu SC, Stijnen T, Plevier JW, Quax PH, Jukema JW. Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review. EuroIntervention. 2011;7:505-16.
2. Krucoff MW, Kereiakes DJ, Petersen JL, Mehran R, Hasselblad V, Lansky AJ, Fitzgerald PJ, Garg J, Turco MA, Simonton CA 3rd, Verheye S, Dubois CL, Gammon R, Batchelor WB, O'Shaughnessy CD, Hermiller JB Jr, Schofer J, Buchbinder M, Wijns W; COSTAR II Investigators Group. A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study. J Am Coll Cardiol. 2008;51:1543-52.
3. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. V 5.1.0. Available at: www.cochrane.org/resources/handbook/. Accessed last time Oct 3rd 2011.
4. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Metaanalysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-12.
5. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991;337:867-72.
6. Egger M, Smith GD. Bias in location and selection of studies. BMJ. 1998;31:61-6.
7. Windecker S, Serruys PW, Wandel S, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Davies S, van Geuns RJ, Eerdmans P, van Es GA, Meeir B, Jüni P. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet. 2008;372:1163-73.